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Protozoan parasites of the genus Leishmania are responsible for causing a variety of human diseases known as leishmaniasis,
which range from self-healing skin lesions to severe infection of visceral organs that are often fatal if left untreated. Leishmania
donovani (L. donovani), the causative agent of visceral leishmaniasis, exemplifys a devious organism that has developed the ability
to invade and replicate within host macrophage. In fact, the parasite has evolved strategies to interfere with a broad range of
signaling processes in macrophage that includes Protein Kinase C, the JAK2/STAT1 cascade, and the MAP Kinase pathway. This
paper focuses on how L. donovani modulates these signaling pathways that favour its survival and persistence in host cells.
1. Introduction
Leishmaniasis, caused by more than 20 species of Leishmania
and transmitted by approximately 30 species of sand fly,
is one of the major infectious diseases affecting 12 million
people worldwide [1–3]. Leishmania are obligate intracel-
lular parasites that infect the hematopoietic cells of the
monocyte/macrophage lineage. They exhibit dimorphic life
cycle, residing as extracellular flagellate promastigotes in the
digestive tract of the sand fly vector and as intracellular flagel-
late amastigotes within macrophage phagolysosome in their
mammalian host [4]. Depending upon the type of species,
infection results in a spectrum of clinical manifestations
ranging from self-healing skin ulcers to disfiguring mucosal
lesions to life-threatening infections of visceral organs (liver
and spleen). Among all these forms, visceral leishmania-
sis (VL, also known as kala-azar), caused by Leishmania
donovani complex (i.e., L. donovani and L. infantum in Old
World and L. chagasi in New World), is often fatal if left
untreated. An estimated annual incidence of 0.5 million
new cases of VL is reported to occur in 62 countries
[5].
Monocytes and macrophages are considered as sentinels
of the immune system. These cells participate in innate
immunity and act as the first line of defence in immune
response to foreign invaders. They also participate in initia-
tion of the acquired immune response by ingesting foreign
particles and presenting them on their surface with major
histocompatibility (MHC) complex. In their resting stage,
macrophages are relatively quiescent, showing low levels of
oxygen consumption, MHC class II gene expression, and
cytokine secretion. But once activated, they exhibit maximal
secretion of factors like IL-1, IL-6, TNF-α, reactive oxygen
species, and nitric oxide produced by inducible nitric oxide
synthase (iNOS) [6]. Production of reactive nitrogen and
oxygen intermediates (RNIs and ROIs) has made these cells
potentially microbicidal [7, 8]. In spite of these, a pathogen
like L. donovani is able to replicate and survive inside these
cells. This suggests that this pathogen has evolved intricate
mechanisms to evade or impair macrophage antimicrobial
functions [9].
The parasite has been observed to interfere with the host
signal transduction in a way that the effector function of
macrophage gets impaired, which in turn facilitates parasite
survival. Signalling pathways inside the cell are tightly
regulated by protein phosphorylation, and levels of cellular
protein phosphorylation are controlled by the activities of
both protein kinases and protein phosphatases [10, 11].
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Therefore, it is not surprising that the parasite interferes
with the protein phosphorylation process, impairing kinase-
phosphatase balance, and hence distorting macrophage’s
antimicrobial functions. This paper, therefore, highlights
the molecular mechanism by which L. donovani modulates
macrophage’s signalling machinery that promotes its intra-
cellular survival and propagation within the host.
2. MAPK Mediated Pathway
Mitogen-activated protein kinases (MAPKs), a group of
serine/threonine-specific protein kinases, constitute one of
the important intracellular signalling pathways in eukary-
otic cells like macrophages, regulating their accessory and
effector functions including production of proinflammatory
cytokines and NO [12]. MAPK family includes extracellu-
lar signal-related kinases 1 and 2 (ERK1/2), c-jun NH2-
terminal kinase (JNK), and p38 MAPK. Activation of these
kinases requires dual phosphorylation of serine/threonine
and tyrosine residues, located in a Thr-X-Tyr motif in
their regulatory domain [12, 13], by upstream kinases
like MAP/ERK Kinase (MEK), which is itself activated by
MEK Kinase (MEKK) [7]. Once activated, these kinases
phosphorylate a number of selected intracellular proteins
including the ubiquitous transcription factors such as acti-
vating protein 1 (AP-1), NF-κB and IFN regulatory factors
(IRFs), because of which a diverse signalling cascade is
triggered that regulates gene expression by transcriptional
and posttranscriptional mechanisms [14–16]. A number of
studies implicated that L. donovani infection of macrophage
leads to the alteration of MAP Kinase pathway, which in
turn promotes parasite survival and propagation within the
host cell. For example, Phorbol 12-myristate 13-acetate-
(PMA-) dependent activation ofMAP kinase and subsequent
expression of c-Fos and elk-1 is impaired in macrophage
infected with L. donovani [17]. Further, the observation
that these effects largely negate when the macrophage
is treated with sodium orthovanadate prior to infection
[17] suggests that Leishmania-induced cellular phosphoty-
rosine phosphatases are responsible for resulting in such
macrophage deactivation. In fact, it was found that the
specific activity of Src homology 2 (SH2) domain containing
PTP (SHP-1) towards MAP Kinase increases in L. donovani-
infected macrophage. Consistent to this, there was also
reported an increased activity of SHP-1 as well as that of total
PTP [18], which apparently supports the finding that SHP-
1-deficient macrophage unlike normal macrophage activates
JAK2, ERK1/2, and the downstream transcription factors,
NF-κB and AP-1 and NO production when treated with
IFN-γ even in infected conditions [19]. Recently, Kar et
al. demonstrated some different phosphatases that are also
induced during Leishmania infection and promotes parasitic
survival. These specificMAPK-directed phosphatases, MKP1
and PP2A, are shown to inhibit ERK1/2 MAP Kinase
resulting in diminished expression of iNOS mRNA [20].
Additional possible mechanism of MAP Kinase inacti-
vation by Leishmania could be explained by the elevation
of endogenous ceramide in parasitised macrophage [21].
Ceramide is an intracellular lipid mediator, which plays
an important role in regulating such diverse responses as
cell cycle arrest, apoptosis, and cell senescence [22]. It exerts
its cellular functions by means of a delicate regulation of
downstream kinases and phosphatases [23]. It was found that
intracellular ceramide dephosphorylates ERK by activating
tyrosine phosphatase [21]. This impairment of ERK is
further shown to attenuate AP-1 and NF-κB transactiva-
tion and production of NO in infected macrophage [24]
(Figure 1). Moreover, these results are in agreement with
previous reports that infection of naı¨ve macrophage with
promastigotes of L. donovani evades activation of MAPKs
leading to impaired proinflammatory cytokines production
[25]. However, treatment of macrophage with IFN-γ prior
to infection is also shown to induce the phosphorylation of
p38 MAPK and ERK1/2 and production of proinflammatory
cytokines [25]. Recently, it was identified that priming of
macrophage with IFN-γ lead to the expression of Toll-like
Receptor 3 (TLR3) which is recognised by the parasite,
leading to production of proinflammatory cytokines like
tumor necrosis factor alpha (TNF-α) and NO [26]. TLR-
mediated regulation of MAP Kinase in macrophage infected
with Leishmania was also demonstrated by Chandra and
Naik. They showed that L. donovani infection of both
THP-1 cells and human monocytes downregulates Toll-
like Receptor 2 (TLR2) and Toll-like Receptor 4 (TLR4),
stimulated IL-12p40 production and increases IL-10 pro-
duction, by suppressing MAPK P38 phosphorylation and
activating ERK1/2 MAP kinase phosphorylation through
a contact-dependent mechanism [27]. As previous studies
have shown that TLR ligation results in phosphorylation
of MAPK p38 and ERK1/2 leading to the production of
IL-12 and IL-10, respectively [28, 29]. Therefore, it seems
that Leishmania infection modulates macrophage function
by counter regulating p38 and ERK1/2 phosphorylation. In
addition, such differential regulation is a direct implication
of parasitic infection without much influence of cytokines
and is evidenced by the observation that neutralisation of
macrophage with anti-IL-10 antibody prior to infection
did not abrogate the suppression of IL-12 production
[27]. A recent study by Rub et al. [30] also showed that
L. major infection of macrophage inhibits CD40-induced
phosphorylation of the kinases Lyn and p38 resulting in
diminished production of IL-12, whereas it upregulates
CD40-induced phosphorylation of the Kinases Syk and
ERK1/2 and enhances the production of IL-10. Moreover,
this has been found to be dependent on the assembly
of distinct CD40 signalosomes which is influenced by the
level of membrane cholesterol. This represents a unique
strategy that the parasite has evolved to survive and needs
to be investigated in case of L. donovani infection of host
macrophage.
The synthetic Leishmania molecule LPG is also shown
to exhibit differential regulation of MAP kinase pathway
in J774 macrophage [31]. By stimulating ERK MAP kinase
that inhibits macrophage IL-12 production, LPG has been
shown to skew the immune response towards Th 2 type. This
suggests that Leishmania parasite employs this molecule to
evade macrophage effector function [31]. But a subsequent
study by Prive´ and Descoteaux contradicted these results that
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Figure 1: Manipulation of macrophage signaling pathways by L. donovani. L. donovani-derived molecules like EF-1α and Fructose 1,6
bisphosphate aldolase activate SHP-1 which negatively affects JAK2, STAT1, ERK1/2, and IRAK-1 inhibiting IFN-γ-induced NO production
and TLR-mediated production of cytokines like IL-12, TNF-α. Impairment of IFN-γ-dependent pathway also includes reduced level of JAK2
expression and proteasome-mediated degradation of STAT1α. NF-κB-dependent pathway is blocked by impaired degradation of IκB. Other
than SHP-1, L. donovani also leads to an enhanced expression of MKP3, PP2A, and MKP1 by inducing PKCζ , and PKCε respectively. These
dual phosphatases or serine/threonine phsophatases inhibit p38 (MKP1) and ERK1/2 (MKP3/PP2A) resulting in upregulation of IL-10 and
downregulation of NO and TNF-α production. PKC-mediated secretion of immunosuppressive molecule PGE2 is also observed. Enhanced
level of endogenous ceramide inhibits PKCβ leading to an impaired oxidative burst. PKC-dependent phosphorylation of MARKS and MRP
and resulting phagosomalmaturation is also inhibited by the parasite. Solid lines: Interaction or positive/negative modulation; dashed lines,
interrupted pathway; MyD88: myeloid differentiation primary-response gene 88; IRAK1: IL-1R-associated Kinase 1; TRAF6: TNF receptor-
associated factor 6.
LPG instead of stimulating ERK exerts inhibitory effect on
ERK activation inmurine bonemarrow-derived macrophage
(BMM) [25]. In addition, the influence of LPG on ERK is
specific as infection of naı¨ve macrophage with LPG defective
parasite was shown to induce ERK activation while having
insignificant effect on p38 and JNK MAP kinase activation
[25]. These findings are further supported by a the obser-
vation that inhibition of the ERK pathway with PD059089
(ERK inhibitor) increases the parasitic survival in infected
macrophage either through increased uptake or decreased
killing of the parasite [32]. Nevertheless, recently it has also
been explained that the Leishmania surface molecule LPG
stimulates the simultaneous activation of all three classes of
MAP kinases, ERKs, JNK, and the p38 MAP kinase with
differential kinetics in J774A.1 macrophage with production
of IL-12 and NO [33]. In conclusion, these demonstrations
suggest that use of different macrophages in respective
studies might have contributed to these contradictory results
and therefore needs additional studies to address such
disparities in alteration of signal transduction pathways in
response to Leishmania infection.
Several studies on Leishmania-dependent modulation
of MAP Kinase pathway implicates that regulation of p38
activation in host macrophage is important in the control
of Leishmania infection. For example, it was demonstrated
that treatment of macrophage with anisomycin, which
activates p38, diminishes the survival of the parasite in
macrophage [32]. This is in consistency with a current
finding that testosterone suppresses L. donovani-induced
activation of p38 and enhances the persistence of the parasite
in macrophage [34]. Furthermore, the observation that the
specific MAPK-directed phosphatase, MKP1, induced by
L. donovani infection downregulated p38 activation and
enhanced the survival of the parasite in macrophage again
emphasizes the importance of p38 MAP Kinase activation in
Leishmania infection [20].
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3. Protein Kinase C-Dependent Pathway
Protein kinase C (PKC) is a family of calcium and phos-
pholipid-dependent serine/threonine kinases having closely
related structures. Based on their intracellular distribution,
cofactor requirement, and substrate specificities, these have
been grouped into three subfamilies, namely, classical PKCs
(cPKC; α, β, γ), novel PKCs (nPKC; δ, ε, η, θ), and
atypical PKCs (aPKCs; ζ , ι, λ), [35–37]. While classical
PKCs are activated by the intracellular second messengers
Ca2+ and diacylglycerol (DAG) together with the membrane
lipid phosphatidylserine (PS), novel PKCs are activated by
diacylglycerol and phosphatidylserine; and atypical PKCs,
whose activity is yet not clearly determined, are apparently
shown to be stimulated by phosphatidylserine [38]. These
kinases reside in the cytosol of the cell in their inactive
conformation. Upon activation by stimuli like hormones
or phorbol esters, they translocate to cell membrane or to
different cell organelles. The mechanism of activation and
the localization to subcellular compartments varies among
the various isoforms [38]. PMA, a well-known phorbol
ester, has been shown to activate [39] and deplete [40]
PKC from cells depending upon the time of incubation.
L. donovani has been shown to evade several macrophage
microbicidal activities by altering PKC-mediated signaling
pathways.
L. donovani promastigotes, amastigotes, and its major
surface molecule LPG have been shown to inhibit PKC-
mediated c-fos gene expression in murine macrophage
while exhibiting little or no effect on PKA-mediated gene
expression [41, 42]. This suggests that the parasite has
selectively evolved PKC inhibitory mechanisms, which assist
in its survival and propagation within the host macrophage.
Interestingly, the observation that LPG-deficient amastigotes
are also able to inhibit PKC-mediated c-fos gene expression
[41], and PKC activity [43] implicates the role of additional
Leishmania molecules in blocking PKC-mediated events.
Indeed, McNeely et al. demonstrated GIPL to be responsible
for PKC inactivation in vitro [44], although its role in
intact macrophage still needs to be determined. L. donovani
infection of human monocytes has also been shown to
attenuate PMA-induced oxidative burst activity and protein
phosphorylation, by impairing PKC activation [43]. Phos-
phorylation of both the PKC-specific VRKRTRLLR substrate
peptide and MARCKS and endogenous PKC substrate is also
shown to be inhibited by LPG treatment of macrophage
[45]. Giorgione et al. further demonstrated by an assay using
large unilamellar vesicles that LPG inhibits PKC-α catalyzed
phosphorylation of histone proteins. This study also showed
that inhibition is likely a result of alterations in the physical
properties of the membrane [46] and supports a recent
finding that uptake and multiplication of parasite increases
in PKC-depleted macrophage having diminished membrane
microviscosity [47]. The level of MARCKS-related proteins
(MRP, MacMARCKS) in macrophage is found to be atten-
uated by all species and strains of Leishmania parasites,
including LPG-deficient Leishmania major L119 [48]. Thus,
this indicates that Leishmania parasites, in addition of
impairing PKC-dependent protein phosphorylation, have
developed a novel mechanism tomodulate downstream PKC
substrates, which interferes with PKC-mediated signalling
pathways. Furthermore, the observation that depletion of
PKC renders macrophages more permissive to the prolifer-
ation of L. donovani again reinforces the fact that inhibition
of PKC-dependent events is one of the important strategies
that the parasite employs, for promoting its survival within
the host cell [45].
One of the studies demonstrated that mere attachment
of parasite on macrophage surface leads to the activation of
PKC and production of O2
 and NO, whereas internalization
of the parasite inhibits these responses [49]. From such
observations, it was suggested that L. donovani attached to
the surface of host cell during initial phase of infection
behaves like other organisms that are killed by macrophages.
But once they are internalized, triggering of these effector
molecules like O2− and NO is switched off in part, due to the
impairment of PKC-mediated signal transduction pathways.
The finding that the activity of PKC increases after it
attaches to the plasma membrane in infected macrophage
appears to indicate that translocation of PKC isoforms
remains unaffected during Leishmania infection [49, 50].
However, the affinity of these isoforms towards their activa-
tor DAG is shown to be diminished in infected macrophage
correlating reduced generation of oxygen radicals [43].
Furthermore, this reduction in affinity has been suggested
to be linked with direct interference of LPG in binding of
the regulators like calcium and DAG to PKC [45]. LPG is
also shown to inhibit phagosomal maturation, a process
requiring depolymerization of periphagosomal F-actin [51].
Holm et al. demonstrated that treatment of macrophage
with LPG induces the accumulation of periphagosomal F-
actin, which was found to be associated with impaired
recruitment of the lysosomal marker LAMP1 and PKCα
to the phagosome [52]. Recently, it was demonstrated that
PKC-α is involved in F-actin turnover in macrophages and
PKC-α-dependent breakdown of periphagosomal F-actin is
required for phagosomal maturation [53]. Therefore, there
is no doubt that LPG inhibits phagosomal maturation by
impairing PKC-α-dependent depolymeristion of F-actin,
resulting in enhanced intracellular survival of the parasite in
infected macrophage [53]. These findings further corrobo-
rate the previous observations that intracellular survival of
the parasite was enhanced by 10- to 20-fold in the murine
macrophage cell line RAW 264.7 overexpressing a dominant-
negative (DN) mutant of PKC-α [54].
Infection of murine cells in vivo and in vitro with
Leishmania parasite has been shown to induce an increased
synthesis of prostaglandin E2 (PGE2) that favours parasite
persistence and progression [55, 56]. Recently, it was demon-
strated that generation of PGE2 in L. donovani-infected
U937 human monocytes is, in part, dependent upon PKC-
mediated signalling pathway [57]. This shows that L. dono-
vani, in addition to downmodulating macrophage functions
by affecting important signalling pathways, induces secretion
of immunosuppressive molecules (e.g., PGE2) to potentially
affect functions of surrounding uninfected cells, which in
turn renders macrophage suitable for the survival and
establishment of the parasite.
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L. donovani infection of macrophage, whereas selectively
attenuates both the expression and activity of calcium-
dependent PKC-β, is shown to induce the expression and
activity of calcium-independent PKC-ζ isoform with dimin-
ished production of O2
− and TNF-α [58]. Attenuation of
the expression and activity of calcium-dependent PKC-β has
been suggested to be mediated by IL-10 overproduction, as
pretreatment of infected macrophage with neutralizing anti-
IL-10 restoring the activity of PKC as well as production
of O2
−, NO, and TNF-α [59]. From these findings, it
can be thus speculated that L. donovani infection induces
endogenous secretion of murine IL-10, in order to facilitate
its intracellular survival via selective impairment of PKC-
mediated signal transduction. One possible mechanism
for this differential regulation of both the expression and
activity of PKC isotypes by Leishmania infection was demon-
strated by Ghosh et al. They elaborated that Leishmania
infection induces elevation of intracellular ceramide in
infected macrophage largely due to its denovo synthesis. The
enhanced ceramide then downregulates classical calcium-
dependent PKC, enhances expression of atypical PKC-ζ
isoform, and diminishes MAPK activity and generation of
NO [21]. Consistent with this, Dey et al. also reported
ceramide-mediated upregulation of atypical PKC-ζ isoform
in infected macrophage. However, they further showed
that this ceramide-induced atypical PKC-ζ inhibits PKB
(Akt) phosphorylation which is dependent upon PKCζ-Akt
interaction, as the treatment of the cell with PKC-ζ inhibitor
prior to infection showed a significant translocation of
Akt from cytoplasm to the membrane [60]. Moreover,
L. donovani infection of macrophage has been found
to induce the expression of MAPK-directed phosphatases
such as MKP1, MKP3, and a thronine/serine phosphatase
PP2A by stimulating various PKC isoforms. While MKP3
and PP2A, activated by PKC-ζ were further found to be
responsible for ERK1/2 dephosphorylation, MKP1 induced
by PKC-ε is shown to inhibit p38 phosphorylation, which
resulted in diminished production of NO and TNF alpha
favouring enhanced survival of the parasite in macrophage
[20]. In conclusion, the observation that C-C chemokines
restore calcium-dependent PKC activity and inhibit calcium-
independent atypical PKC activity in L. donovani-infected
macrophages under both in vivo and in vitro conditions
restricting the parasitic load again supports the fact that
impairment of PKC-mediated signaling is a key to the
establishment of Leishmania parasites in their host cells [61].
4. JAK2/STAT1-Dependent Pathway
IFN-γ is a potent cytokine that induces macrophage acti-
vation and helps resisting Leishmania infection [62, 63]. It
mediates its biological functions via IFN-γ receptor- (IFN-
γR-) mediated pathway involving receptor-associated kinases
JAK1/JAK2 and STAT-1 [64, 65]. Binding of IFN-γ to its
multisubunit receptor triggers its dimerization and allows
transphosphorylation of the Jak1 and Jak2. These kinases
in turn phosphorylate the cytoplasmic tail of the receptor
itself which recruits the cytoplasmic molecule STAT1α.
This transcription factor is then phosphorylated, becomes
a homodimer, and then translocates to the nucleus to
enhance transcription of IFN-γ-induced genes, such as FcgRI
[66]. Leishmania induced macrophage dysfunction such as
defective production of NO [67] and MHC [68] expression
in response to IFN-γ may not exclude the possibility that
the parasite could have impaired this pathway. In fact, a
number of studies implicated Leishmania-mediated impair-
ment of JAK2/STAT1 pathway, which correlates with such
macrophage deactivation. For instance, one of the studies
showed that L. donovani infection attenuates IFN-γ-induced
tyrosine phosphorylation and selectively impairs IFN-γ-
induced Jak1 and Jak2 activation and phosphorylation of
Stat1 in both differentiated U-937 cells and human mono-
cytes [69]. A probable mechanism for this was demonstrated
by Blanchette et al. that L. donovani infection of macrophage
rapidly induces host PTP activity simultaneously with
dephosphorylation of macrophage protein tyrosyl residues
and inhibition of protein tyrosine kinase [18]. They further
revealed that upon infection, PTP SHP-1 is also rapidly
induced, which interacts strongly with JAK2, and impairs
IFN-γ signaling [18]. However, a recent observation that
IFN-γ-stimulated STAT1α activity is also reduced in SHP-1-
deficient macrophages following L. donovani infection indi-
cates that Leishmania employs further mechanisms to inhibit
STAT1 activity [19]. One possible mechanism could be the
proteasome-mediated degradation of STAT1α in infected
macrophage, as treatment of macrophage with proteasome
inhibitors prior to infection is shown to rescue STAT1α
nuclear translocation as well as restore its general protein
level in Leishmania-infected macrophage [70]. Additionally,
L. donovani infection of macrophage has been shown to
attenuate IFN-γR alpha subunit expression [71] and induce
the transient expression of the cytokine signaling 3 (SOCS3)
[72], which also shown to negatively regulate IFN-γ signal-
ing. More recently, L. donovani amastigote is found to inhibit
the expression of IRF-1 while having no effect on STAT1α
protein levels. This inhibition of IRF-1 expression correlates
with the defective nuclear translocation of STAT1 and further
revealed that the IFN-induced STAT1α association with the
nuclear transport adaptor importin-5 is compromised in
L. donovani amastigote-infected macrophage [73]. These
results thus provide evidence for a novel mechanism used
by L. donovani to interfere with IFN-γ-activated macrophage
functions.
5. Implication of Phosphatases
Protein phosphatases are key regulatory components in
signal transduction pathways [74, 75]. Based on their
substrate specificity, these have been divided into two main
groups. One of them specifically hydrolyzes serine/threonine
phosphoesters (PPs) and the other is phosphotyrosine
specific called protein tyrosine phosphatases (PTPs). Apart
from these, a subfamily of PTPs also exists that are capable of
efficiently hydrolysing both phosphotyrosine and phospho-
serine/threonine residues and are therefore known as dual-
specificity phosphatases. PTP-regulated protein dephospho-
rylation is a critical control mechanism for numerous physi-
ological processes such as cell growth, motility, metabolism,
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cell cycle regulation, and cytoskeletal integrity [76, 77].
However, for parasites like Leishmania these molecules have
been proved fruitful in enhancing their survival within
host macrophage by inhibiting several intracellular signaling
cascades involved in host effector functions.
5.1. SHP-1 Protein Tyrosine Phosphatase. Protein Tyrosine
Phosphatases containing Src homology 2 (SH2) domains
have been identified in a wide variety of species [74, 75]. One
of them is PTP SHP-1, which is also known as PTP1C, HCP,
SHPTP1, and SHP [75]. This phosphatase is expressed not
only in haematopoietic cells but also in smooth muscle [78]
and epithelial cells [79] and is considered as an important
negative regulator of numerous signaling pathways, such
as those related to the actions of interferons [80, 81] and
erythropoietin [82, 83].
Structural analysis of SHP-1 showed that this phos-
phatase contains two SH2 domains in its N-terminal portion,
a phosphatase domain conserved in a central position and
a C-terminal tail [84]. The SH2 domains which contain
specific amino acid sequences have been found to inter-
act with the target protein through an immunoreceptor
tyrosine-based inhibitory motif (ITIMs) within the consen-
sus sequence I/V/LxYxxL/V [85]. These specialized motifs
are known to be present in many signaling molecules [86,
87], and multiple types of ITIMs exist and display specific
abilities to recruit and activate SH2 containing PTPs. SHP-1
has been shown to bind to receptors and dephosphorylate
them directly or associate with a receptor and dephos-
phorylate other members of the receptor binding complex.
Moreover, it also interacts with other cytosolic proteins
and was found to dephosphorylate them or their associated
proteins [86]. Several studies on Leishmania infection have
implicated a negative role of these phosphatases.
A study by Olivier et al. for the first time demonstrated
a role of protein tyrosine phosphatases in Leishmania
infection, by using PTP inhibitors such as the peroxo-
vanadium (pv) compound bpv(phen), which restricted the
progression of both visceral and cutaneous leishmaniasis in
vitro as well as in vivo [88]. Consistent with this, Blanchette
et al. showed that L. donovani infection of macrophage
induces a rapid elevation of total PTP activity and SHP-
1 activity, leading to a widespread dephosphorylation of
high-molecular-weight proteins [18]. In addition, activated
SHP-1 is observed to interact with JAK2 and impair
its activation in response to IFN-γ [18]. Accordingly, it
was also found that Leishmania-induced SHP-1 interacts
strongly with MAP kinases and impairs PMA-stimulated
ERK1/2 phosphorylation, Elk-1 activation, and c-fos mRNA
expression resulting in attenuated expression of iNOS [17].
These results are strongly supported by a recent finding that
infection of SHP-1 deficient macrophage with L. donovani
exhibits normal JAK2 and ERK1/2 activity and increased
NO production in response to IFNγ [19]. Taken together,
these findings suggest that L. donovani exploits host PTP
SHP-1 in modulating several key signalling molecules to
evade macrophage effector functions.
Studies aimed at understanding the mechanism respon-
sible for the change in activation state of SHP-1 led to
the identification of Leishmania EF-1α and subsequently
fructose-1,6 bisphosphate aldolase, which were shown to
bind and activate PTP SHP-1 in vitro and in vivo, in a similar
fashion [89, 90]. In both these cases, although the trafficking
mechanism of the molecules is not yet clear, it appears that
they are exported out of the phagosome into the cytosol,
where they activate SHP-1 [89, 90]. These observations lead
to the speculation that more than one Leishmania-derived
molecule is likely to be needed for optimum activation
of SHP-1 as these molecules are reported to cooperate in
activating this PTP by interacting at different sites on it [90].
SHP-1 is also shown to inhibit a critical kinase (IRAK-1)
involved TLR signaling. This has been linked to a rapid
binding of SHP-1 with IRAK-1 through an evolutionarily
conserved ITIM-like motif identified in the kinase. This
motif was also present in other kinases involved in Toll
signalling and therefore could represent a regulatory mech-
anism of relevance to many kinases. This work therefore
reports a unique mechanism by which Leishmania can avoid
harmful TLR signalling [91].
5.2. Other Phosphatases. It is apparent from several studies
that SHP-1 plays an important role in pathogenesis during
Leishmania infection. Nevertheless, the finding that SHP-1-
deficient macrophage witnessed an increased PTP activity
and inhibition of NF-κB and AP-1 during L. donovani infec-
tion points to the induction of additional PTPs that could
also be involved in disease progression [19]. In fact, Olivier
et al. showed that macrophage PTP-1B is rapidly induced
upon Leishmania infection (Gomez and Olivier, unpublished
data), although the underlying mechanism involved in its
activation and in its enrolment in macrophage dysfunction
during L. donovani infection remains undiscovered and
needs further investigations. The elevated level of endoge-
nous ceramide, generated during Leishmania infection, is
shown to activate a vanadate-sensitive tyrosine phosphatase
which dephosphorylates ERK1/2 resulting in a diminished
production of NO [21]. Similarly, Dey et al. described
another phosphatase PP2A, induced during L. donovani
infection of macrophage, mediated through ceramide. PP2A
was found to inhibit PKB (Akt), a kinase involved in respi-
ratory burst activity in infected macrophage, and enhanced
survival of the parasite in infected macrophage [60]. L. dono-
vani infection of macrophage is also shown to induce a
significant upregulation of a serine/threonine phosphatase
PP2A and two specific MAPK-directed phosphatases such
as MKP1 and MKP3. [20]. While MKP3- and PP2A- medi-
ated dephosphorylation of ERK1/2 resulted in substantial
decrease in iNOS expression in infected macrophage, MKP1
is shown to skew cytokine balance towards Th2 response that
favoured persistence and propagation of the disease in in
vitro as well as in vivo model of Leishmania infection [20].
6. Conclusion
Parasitic protozoa like Leishmania are a major cause of
severe morbidity and mortality in several parts of the world.
These pathogens have evolved with the mammalian immune
system and typically produce long lasting chronic infections.
Molecular Biology International 7
They exhibit an efficient survival in host macrophage by
manipulating host signaling machinery in its favour. This
paper has covered some of these mechanisms which would
facilitate further studies in knowing the unidentified strate-
gies that the parasite employs in subverting host immune
system. Moreover, given that these signalling pathways could
be manipulated pharmacologically, an improved under-
standing of the host parasite interaction would allow the
development of new therapies to control such infectious
agents.
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